India Glycols Limited (INDIAGLYCO) Price & Analysis

Compare

2 Followers

INDIAGLYCO Stock Chart & Stats

₹1007.65

-₹68.05(-5.10%)

At close: Jan 08 4:00 PM EST

₹1007.65

-₹68.05(-5.10%)

Day’s Range― - ―

52-Week Range₹502.50 - ₹1,222.85

Previous CloseN/A

Volume301.52K

Average Volume (3M)19.23K

Market Cap

₹62.20B

Enterprise Value₹82.38B

Total Cash (Recent Filing)₹774.40M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)21.3

Beta1.80

Next Earnings

May 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.47%

Share Statistics

EPS (TTM)10.05

Shares Outstanding67,026,764

10 Day Avg. Volume24,007

30 Day Avg. Volume19,229

Financial Highlights & Ratios

PEG Ratio0.23

Price to Book (P/B)0.79

Price to Sales (P/S)0.47

P/FCF Ratio-4.48

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)51.77

Revenue Forecast (FY)₹43.07B

Bulls Say, Bears Say

Bulls Say

Renewable Feedstock BaseA renewable, agro-derived feedstock base reduces dependence on fossil feedstocks and commodity oil cycles, aligning the business with durable sustainability trends and regulatory preference. This supports long-term supply resilience, potential cost stability, and stronger customer demand in green-sensitive end markets.

Specialty Derivatives And Diversified End-marketsA focus on downstream derivatives and specialty chemicals (solvents, personal care, pharma intermediates, coatings) shifts revenue mix away from pure commodities. This structural move supports higher, more stable margins, reduces cyclicality, and increases customer stickiness across multiple industrial end-markets.

Improved Equity Returns And Stable Equity BaseAn improved ROE (10.2%) with a stable equity ratio indicates better capital efficiency and a reasonable equity cushion. Over the medium term this supports reinvestment capacity and credibility with lenders, enabling strategic growth while maintaining a measured balance between debt and equity financing.

Bears Say

Rising LeverageHigher debt-to-equity increases financial risk and interest burden, reducing strategic flexibility. Over 2-6 months this raises refinancing and covenant exposure, constrains capital allocation for capex or M&A, and elevates vulnerability to demand downturns or input-cost shocks.

Negative Free Cash FlowSustained negative free cash flow driven by high capex limits capacity to pay down debt, fund dividends, or invest organically. Without improvement, this constrains financial flexibility, may force external financing, and increases execution risk for strategic initiatives over the medium term.

Slowing Revenue Growth And Margin PressureA deceleration in revenue growth and reported margin pressures reduce operating leverage and long-term earnings upside. If sustained, slower top-line expansion combined with margin compression will challenge sustained profitability improvements and strain the company’s ability to deleverage or reinvest.

India Glycols Limited News

India Glycols Announces Trading Window Closure Ahead of Financial Results Meeting

India Glycols Limited ( ($IN:INDIAGLYCO) ) has shared an announcement. India Glycols Limited has announced the closure of...

4M ago

India Glycols Announces Dividend Post Share Split

India Glycols Limited ( ($IN:INDIAGLYCO) ) just unveiled an update. India Glycols Limited announced a dividend for the...

5M ago

INDIAGLYCO FAQ

What was India Glycols Limited’s price range in the past 12 months?

India Glycols Limited lowest stock price was ₹502.50 and its highest was ₹1222.85 in the past 12 months.

What is India Glycols Limited’s market cap?

India Glycols Limited’s market cap is ₹62.20B.

When is India Glycols Limited’s upcoming earnings report date?

India Glycols Limited’s upcoming earnings report date is May 21, 2026 which is in 83 days.

How were India Glycols Limited’s earnings last quarter?

India Glycols Limited released its earnings results on Feb 10, 2026. The company reported ₹10.05 earnings per share for the quarter, beating the consensus estimate of N/A by ₹10.05.

Is India Glycols Limited overvalued?

According to Wall Street analysts India Glycols Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does India Glycols Limited pay dividends?

India Glycols Limited pays a Annually dividend of ₹5 which represents an annual dividend yield of 0.47%. See more information on India Glycols Limited dividends here

What is India Glycols Limited’s EPS estimate?

India Glycols Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does India Glycols Limited have?

India Glycols Limited has 67,026,764 shares outstanding.

What happened to India Glycols Limited’s price movement after its last earnings report?

India Glycols Limited reported an EPS of ₹10.05 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.87%.

Which hedge fund is a major shareholder of India Glycols Limited?

Currently, no hedge funds are holding shares in IN:INDIAGLYCO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

India Glycols Limited

India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. The company operates through Industrial Chemical, Ethyl Alcohol, and Nutraceuticals segments. It offers monoethylene, diethylene, and triethylene glycols; polyethylene glycols; fatty alcohol, acid, and amine ethoxylates; alkyl phenol ethoxylates; castor/natural oil ethoxylates; and ethoxylated and propoxylated co-polymers. The company also provides polysorbates; glycol ethers and acetates; brake fluids and anti-freeze coolants; performance chemicals; natural gums, including guar gums and other hydrocolloid products; extra neutral alcohols/rectified spirits; Indian-made foreign liquor; and alcohol-based hand sanitizers. In addition, it offers natural active pharmaceutical ingredients, standardized botanical and herbal extracts, and spice extracts; and industrial gases, such as liquid oxygen, argon, nitrogen, and carbon dioxide, as well as IGL Steri-gas ethylene oxide and carbon dioxide gas mixtures. The company also exports its products. It serves agrochemical, automotive, detergent, healthcare and food processing, mining, oil and gas, paper, personal care, pharmaceutical, paint and emulsion polymerization, textile, and other industries. The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India.